Indonesia IMTC contributes to MDR-TB management in Indonesia and works with countries to expand clinical and programmatic capacity to diagnose and treat MDR-TB, including increasing the availability of hospital-based treatment services. In addition, Indonesia IMTC™ is a key partner in the introduction of community-based MDR-TB treatment systems.
In Indonesia, this project introducing community-based MDR-TB care and designed to assist NTPs and other non-governmental organizations (NGOs) to accelerate the implementation of the Programmatic Management of Drug Resistant TB (PMDT) programs. Indonesia IMTC™ programs work with a wide segment of stakeholders, including hospital association, respiratory society, CDC-MOH, R&D-MOH, international organizations, communities, and patients to scale up evidence-based interventions and improve outcomes in MDR-TB prevention and control. It offers guidance to minimize TB infection within hospitals, improve the quality of life, and provides support so that patients can complete treatment while maintaining interaction with their families and communities.
Establish in Jakarta, since February 2015.